The mystery of a poorly understood and serious childhood
condition - Kawasaki Disease - is a step closer to being solved
after a team of international researchers, including from Murdoch
Childrens Research Institute, identified two genes that are
important in determining who develops Kawasaki disease.
The study found that children who have had Kawasaki disease have
naturally occurring variation in two key genes involved in the
immune response. The findings, which are published today in
the leading scientific journalNature Genetics,could help
revolutionise diagnosis and treatment of the disease.
Kawasaki disease is a serious illness affecting young children
and may cause symptoms including high fever, rash, swollen hands,
red eyes, enlarged glands in the neck and redness of the tongue and
lips. In up to a quarter of untreated children, the blood vessels
supplying the heart - the coronary arteries - are affected.
Kawasaki disease is one of the most common causes of heart
disease acquired during childhood. The heart problems can persist
through life and may require coronary artery bypass or rarely even
heart transplant. Occasionally Kawasaki disease can be fatal. In
Australia, there are believed to be around 200 cases of Kawasaki
disease each year and there are thousands more worldwide.
In the largest study ever to have been conducted on Kawasaki
disease (with a total of 2173 cases and 9383 controls),
collaborating physicians and scientists from over 70 centres in 11
countries analysed almost 500,000 genetic markers in
European-Caucasian cases and controls and then confirmed the
findings in Kawasaki disease patients from Australia, Europe, the
US, Canada and Asia. They identified the two mutated genes in 5
different cohorts of Kawasaki disease patients.
The study found that one of the altered genes is a receptor for
both the body's own antibodies and for intravenous immunoglobulin,
antibodies derived from donated blood that is the mainstay of
Kawasaki disease treatment. The other gene appears to be involved
in regulating the strength of the immune response to infection.
One of the lead researchers, Dr David Burgner, from the Murdoch
Childrens Research Institute, says the discovery is an important
step towards understanding the condition that has fascinated and
frustrated pediatricians and families for decades since its first
description in the 1970s.
"Kawasaki Disease is familiar to every pediatrician, but there
is no diagnostic test and it can be difficult to diagnose.
Similarly, as we don't fully understand the condition, current
treatment is non-specific and it doesn't always prevent heart
damage - the most serious complication," David said.
"However in this study we discovered that when these two
genes are mutated, this significantly contributes to the risk of
developing Kawasaki Disease, which is a major step forward into
understanding and treating this disease. We hope that these
findings are an important piece of the jigsaw of Kawasaki disease
and will help with the search for easier diagnosis and better
treatment."
"It is gratifying that Australian families and researchers played
a major role in this important study. The findings will provide
important basis for ongoing research and this will hopefully lead
to benefits for patients, their families and their doctors."